Track record · closed signal

Aveanna Healthcare Holdings Inc. (AVAH) — closed signal from September 23, 2025

Partial Published before the outcome was known, scored automatically when the window closed on December 22, 2025.

Predicted vs. what happened

AVAH price · publication thesis → realized outcomesplit-adjusted
$8.51 Published $11.06 Target $8.93 Window close $10.32 Peak
$8.30 – $8.70Entry zone — fair-value band
$8.51Published — price the day we called it
$11.06Target — the price the thesis aimed for
$10.32Peak — highest point inside the window, not a realized return
$8.93Window close — end-of-window price, context only

What happened

Partial

Reached 71% of the predicted growth at its peak, without hitting the target.

Peak price
$10.32
peak on October 21, 2025 — not a realized return
Peak gain
+21.3%
peak, from the publication price
Window close
$8.93
end-of-window price, context only
Days to target
—
Window
September 23, 2025 – December 22, 2025

The thesis — published September 23, 2025

Predicted growth
+30%
over the measurement window
Target price
$11.06
the price the thesis aimed for
Entry zone
$8.30 – $8.70
the fair-value band we waited for
Price at publication
$8.51
published September 23, 2025
Confidence
66%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Aveanna looks like a recovery story that is starting to win back trust. It lowered risk by reworking $1.325B of main debt and paying off $415M of higher-cost debt. JP Morgan lifted its view to a price of 10 and upgraded the stock, which helped it reach a new yearly high. The upward trend is real, but the business results are still thin. Over the next 3 months, progress will hinge on execution, hiring enough staff, and steady insurance pay, so keep positions small.

Primary drivers

  • Refinancing lowers risk and interest costs, improving stability
  • Target raised to 10 and an upgrade attract more investor attention
  • New yearly high signals strong buyer interest and better sentiment
  • Aging population supports long-term need for home health services

How it played out

AVAH: thesis partly played out but target was missed

Lyra published AVAH at 8.51 on September 23, 2025, with expected growth of 30%. The thesis pointed to lower risk after reworking 1.325B of main debt and paying off 415M of higher-cost debt. It also pointed to a raised view at 10, an upgrade, a new yearly high, and long-term need for home health services.

Inside the September 23 to December 22, 2025 window, AVAH rose to 10.32 on October 21, 2025. That was a 21.3% peak gain, but it stayed below the 11.06 target. It never got there. The stock ended at 8.93. The call partly worked, but the published target was missed.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All AVAH signals